FR2693106A1 - Extract contg. aromatic isothiocyanate, thiocarbamate, and thiourea - for the treatment of functional metrorrhagia, and as a venous tonic and free radical trap - Google Patents

Extract contg. aromatic isothiocyanate, thiocarbamate, and thiourea - for the treatment of functional metrorrhagia, and as a venous tonic and free radical trap Download PDF

Info

Publication number
FR2693106A1
FR2693106A1 FR9212179A FR9212179A FR2693106A1 FR 2693106 A1 FR2693106 A1 FR 2693106A1 FR 9212179 A FR9212179 A FR 9212179A FR 9212179 A FR9212179 A FR 9212179A FR 2693106 A1 FR2693106 A1 FR 2693106A1
Authority
FR
France
Prior art keywords
thiocarbamate
thiourea
treatment
isothiocyanate
free radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR9212179A
Other languages
French (fr)
Inventor
Docteur Thomas Wandji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9212179A priority Critical patent/FR2693106A1/en
Publication of FR2693106A1 publication Critical patent/FR2693106A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compositions containing three compounds which have, respectively, isothiocyanate, thiocarbamate, and thiourea groups attached to benzene rings, are new. The compsns. are obtd. from extracts of Pentadiplandra Brazzeana, and contain propyl 2-anisyl-1-methyl isothiocyanate (I), ethyl N-benzyl thiocarbamate (II) and N,N-dibenzyl thiourea (III). USE - As a syrup, the compositions are useful in the treatment of functional metrorrhagia and as a powerful venous tonic. As a pomade the compositions may be used to trap free radicals.

Description

TITRE : ASSOCIATIOK EE TROIS PRINCIPES ACTIFS EXTRAITS
DU PENTADIPLANDRA BRAZZEANA
La présente invention se rapporte à une association de trois composés à noyaux benzéniques ayant des portions isothiocyanate, thiocarbamate, et thiourée tous de provenance naturelle
Bien que des dérivés de THIOCARBAMATES, ISOTHIOCYANATES et
THIOURE'aient fait l'objet de nombreux travaux, il n'a pas encore e été fait cependant états en thérapeutique, de leur association surtout en tant que substance provenant de source naturelle.
TITLE: ASSOCIATIOK EE THREE ACTIVE EXTRACT PRINCIPLES
PENTADIPLANDRA BRAZZEANA
The present invention relates to a combination of three compounds with benzene rings having isothiocyanate, thiocarbamate, and thiourea portions, all of natural origin.
Although derivatives of THIOCARBAMATES, ISOTHIOCYANATES and
THIOURE 'have been the subject of numerous works, it has not yet been reported in therapy, their association especially as a substance from a natural source.

Pris séparéments les trois composés, susceptibles d'être mélangés et faisant l'objet de la prudente invention sont 1- ANISYL - 2 METHYL -1 ISOTHIOCYANATE DE PROPYLE 2- bE N-BENZYLTHIOCARBAMATE D'ETIIYLE. Taken separately, the three compounds which can be mixed and which are the subject of the prudent invention are 1- ANISYL - 2 METHYL -1 PROPYL ISOTHIOCYANATE 2- BEE N-BENZYLTHIOCARBAMATE.

3-N,N-DIBENZYLTHIOUREE:
Les trois composés ainsi décrits peuvent être obtenus à l'etat pure par extraction à partir de la plante connue sous le nom scientifique de PENTADIPLANDRA BRAZZEANA
La methode d'extraction des trais éléments est décrite dans la demande de brevet déposée à l'C.A.P.I. sous le na 54335. Une fois extraite de leur milieu naturel l'on obtient trois composés se présentant sous forme de poudre plus ou moins blanche.
3-N, N-DIBENZYLTHIOUREE:
The three compounds thus described can be obtained in their pure state by extraction from the plant known under the scientific name of PENTADIPLANDRA BRAZZEANA
The method for extracting the elements is described in the patent application filed with the CAPI under na 54335. Once extracted from their natural environment, three compounds are obtained which are in the form of more or less white powder.

A titre de produis nouveau, l'associaiton des trois molécules s'est révélée avoir des propriétés therapeutiques remarquables dans le traitement de certainss affections notamment dans les cas de métrorragies fonctionnelles.  As a new product, the combination of the three molecules has been shown to have remarkable therapeutic properties in the treatment of certain ailments, especially in cases of functional bleeding.

FORMULE MEDICAMENTEUSE
Element 1 = ANISYL - 2 METHYL - 1 ISOTHIOCYANATE DE PROPYLE
Element 2 = N-BENZYL THIOCARBAMATE D'ETHYLE
Element 3 = N,N-DIBENZYL THIOUREE
Ces trois éléments sont mis en association dans les proportions suivantes:
Element 1 ............ 21,10 %
Element 2 ............ 29,36 %
Element 3 ............ 49,54 %
Additionné d'autres excipients, le produit résultant se présente sous forme de sirop, forme qui ne constitue cependant pas une limitation.
DRUG FORMULA
Element 1 = ANISYL - 2 METHYL - 1 PROPYL ISOTHIOCYANATE
Element 2 = N-BENZYL ETHYL THIOCARBAMATE
Element 3 = N, N-DIBENZYL THIOUREE
These three elements are combined in the following proportions:
Element 1 ............ 21.10%
Element 2 ............ 29.36%
Element 3 ............ 49.54%
Added to other excipients, the resulting product is in the form of syrup, a form which however does not constitute a limitation.

INDICATIONS THERAPEUTIQUES -METRORRAGIES FONCTIONNELLES. THERAPEUTIC INDICATIONS - FUNCTIONAL METRORAGIES.

-TONIQUE VEINEUSE PUISSANT.- POWERFUL VENOUS TONIC.

-SOUS FORME DE POMMADE : PIEGE LES RADICAUX LIBRES
Le produit ainsi formulé a été administré à des malades avec des résultats surprenants ce qui a permis de déduire son éfficacité.
- IN THE FORM OF OINTMENT: TRAP FREE RADICALS
The product thus formulated was administered to patients with surprising results, which made it possible to deduce its effectiveness.

Claims (5)

REVENDICATIONS 1)-Composition à usage thérapeutique constituée par l'association de trois composés à noyaux benzeniques ayant des portions isothiocyanate thiocarbamate et thiourée. 1) -Composition for therapeutic use constituted by the association of three compounds with benzenic nuclei having isothiocyanate, thiocarbamate and thiourea portions. 2)-Composition selon la revendication caractérisée en ce que les trois composés provenant de source naturelle sont extraits à partir du rentadiplandra Brazzeana.  2) -Composition according to claim characterized in that the three compounds from natural source are extracted from rentadiplandra Brazzeana. 3)-Composition selon les revendications 1 et 2 caractérisée en ce que le premier élément est le : ANISYL - 2 METHYL - 1 ISOTHIOCYANATE 3) -Composition according to claims 1 and 2 characterized in that the first element is: ANISYL - 2 METHYL - 1 ISOTHIOCYANATE DE PROPYLEP le second le N-BENZYLTHIOCARBOMATE D'ETHYLE et le troisiéme le N,N-DIBENZYLTHIOUREE.OF PROPYLEP the second the N-BENZYLTHIOCARBOMATE of ETHYLE and the third the N, N-DIBENZYLTHIOUREE. 4)-Composition selon les revendications 1, 2 et 3 caractérisée en ce qus le dosage du melange est effectué dans les proportions de 4) -Composition according to claims 1, 2 and 3 characterized in that the dosage of the mixture is carried out in the proportions of Elément 1 .......... 21,10 % Element 1 .......... 21.10% Elément 2 ............. 29,36 % Element 2 ............. 29.36% Elément 3 ............ 49,,4 % Element 3 ............ 49,, 4% 5)-Composition selon les revendications 1 à 4 caractérisée en ce que le produit préparé sous lune quelconque des formes administrables est utilisé dans le traitement des métrorragies fonction -nelles ainsi que comme tonique veineuse.  5) -Composition according to claims 1 to 4 characterized in that the product prepared in any one of the administrable forms is used in the treatment of functional metrorrhagia as well as as a venous tonic.
FR9212179A 1992-10-02 1992-10-02 Extract contg. aromatic isothiocyanate, thiocarbamate, and thiourea - for the treatment of functional metrorrhagia, and as a venous tonic and free radical trap Pending FR2693106A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9212179A FR2693106A1 (en) 1992-10-02 1992-10-02 Extract contg. aromatic isothiocyanate, thiocarbamate, and thiourea - for the treatment of functional metrorrhagia, and as a venous tonic and free radical trap

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9212179A FR2693106A1 (en) 1992-10-02 1992-10-02 Extract contg. aromatic isothiocyanate, thiocarbamate, and thiourea - for the treatment of functional metrorrhagia, and as a venous tonic and free radical trap

Publications (1)

Publication Number Publication Date
FR2693106A1 true FR2693106A1 (en) 1994-01-07

Family

ID=9434445

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9212179A Pending FR2693106A1 (en) 1992-10-02 1992-10-02 Extract contg. aromatic isothiocyanate, thiocarbamate, and thiourea - for the treatment of functional metrorrhagia, and as a venous tonic and free radical trap

Country Status (1)

Country Link
FR (1) FR2693106A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003084557A1 (en) * 2002-04-05 2003-10-16 Thomas Wandji Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family
WO2003084523A1 (en) * 2002-04-05 2003-10-16 Thomas Wandji Use of a n,n'-dibenzyl-thiourea as medicine
FR2988000A1 (en) * 2012-03-16 2013-09-20 Thomas Wandji Combination of propylene methoxy-4-phenyl-2-methyl-2-isothiocyanate, N,N-dibenzylthiourea in the form of hydroalcoholic solution (anti oxidant), beta-sitosterol and stigmasterol as an antiviral drug, for killing human and animal viruses
EP2966060A4 (en) * 2013-03-05 2016-08-03 Asahi Kasei Chemicals Corp Isothiocyanate production method, composition for transporting and storing n-substituted o-substituted thiocarbamate, and isothiocyanate composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2166349A1 (en) * 1972-01-04 1973-08-17 Wandji Thomas Difeu alkaloids - for treating diarrhoea, peptic ulcer anorexia, as a diuretic, as a sclerosing agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2166349A1 (en) * 1972-01-04 1973-08-17 Wandji Thomas Difeu alkaloids - for treating diarrhoea, peptic ulcer anorexia, as a diuretic, as a sclerosing agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MIGIRAB S E ET AL: "ISOTHIOCYANATES, THIOUREAS AND THIOCARBAMATES ISOLES DE PENTADIPLANDRA BRAZZEANA", PHYTOCHEMISTRY (OXF),, VOL. 16, NO. 11). 1977 1719-1722, PHYTOCHEMISTRY (OXF) 16 (11). 1977 1719-1722. CODEN: (NO ISSN): PYTC *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003084557A1 (en) * 2002-04-05 2003-10-16 Thomas Wandji Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family
WO2003084523A1 (en) * 2002-04-05 2003-10-16 Thomas Wandji Use of a n,n'-dibenzyl-thiourea as medicine
JP2005524681A (en) * 2002-04-05 2005-08-18 トーマス、ワンジ Method for extracting a novel compound from the roots of a plant of the Pentadiplandracea family
CN1646149B (en) * 2002-04-05 2012-03-21 T·万德吉 Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family
FR2988000A1 (en) * 2012-03-16 2013-09-20 Thomas Wandji Combination of propylene methoxy-4-phenyl-2-methyl-2-isothiocyanate, N,N-dibenzylthiourea in the form of hydroalcoholic solution (anti oxidant), beta-sitosterol and stigmasterol as an antiviral drug, for killing human and animal viruses
EP2966060A4 (en) * 2013-03-05 2016-08-03 Asahi Kasei Chemicals Corp Isothiocyanate production method, composition for transporting and storing n-substituted o-substituted thiocarbamate, and isothiocyanate composition
EP3214071A1 (en) * 2013-03-05 2017-09-06 Asahi Kasei Chemicals Corporation Isothiocyanate composition
US10308601B2 (en) 2013-03-05 2019-06-04 Asahi Kasei Chemicals Corporation Isothiocyanate production method, composition for transporting and storing N-substituted O-substituted thiocarbamate, and isothiocyanate composition
US11046645B2 (en) * 2013-03-05 2021-06-29 Asahi Kasei Chemicals Corporation Isothiocyanate production method, composition for transporting and storing N-substituted O-substituted thiocarbamate, and isothiocyanate composition

Similar Documents

Publication Publication Date Title
EP0022046B1 (en) Drug composition based on plants and process for its preparation
EA002789B1 (en) Substance mixture for topical application
JP2001501950A (en) Use of bisphenol compounds for treating type II diabetes
US5846944A (en) Purified SDG as an antioxidant
FR2693106A1 (en) Extract contg. aromatic isothiocyanate, thiocarbamate, and thiourea - for the treatment of functional metrorrhagia, and as a venous tonic and free radical trap
EP0957928A1 (en) Plant extract compositions, method of preparation, and pharmaceutical compositions containing them
KR20130088538A (en) Extracting method of dendropanax morbifera leveille extract
Biswas et al. A review on animal-based homoeopathic drugs and their applications in biomedicine
KR100418688B1 (en) The growth inhibition of Propionibacterium acnes for the multiple extracts of herbal medicaments
Babaei et al. Cucurbita maxima (Pumpkin) seeds: Scolicidal activity and preventive efficacy of its extract on experimental hydatidosis in mice
Sangare et al. Effets de l’extrait aqueux de gomphrena celosioides (amaranthaceae) sur les enzymes hépatiques
EP1049480A1 (en) Herbal anti-viral agent
WO2013012302A2 (en) Production of a natural anti-inflammatory/anti-oedema syrup based on aqueous extracts of plants originating from the south-east of morocco
EP0739629A1 (en) Associations comprising (-)hydroxycitrate and having new therapeutical activities
FR2666228A1 (en) Composition for the treatment of excessive weight and/or of cellulite
Ghaffarie et al. Effect of hydroalcoholic extract of cinnamon on the pituitary-gonadal axis in adult male rats under chemotherapy by cyclophosphamide
CH630803A5 (en) Medicinal preparations, for the treatment of hypercholesterolaemia in particular
FR2557797A1 (en) Terminalia chebula-based therapeutic composition for the oral treatment of psoriasis
WO1984004249A2 (en) Composition having an improved pharmaceutical activity and utilisation thereof in veterinary medecine
US12029771B2 (en) Neem for treatment of RLS
FR2710266A1 (en) New compositions in cosmetology and dermatology proposed in the treatment of warts
KR0165938B1 (en) Hair growth stimulating composition containing extract of artemisia apiaceahance
CA2563381C (en) Use of purified sdg as an antioxidant
FR2884425A1 (en) Pharmaceutical or cosmetic composition, useful to treat psoriasis, comprises marine lecithin, which is having marine phospholipid concentrate
Singh ROLE OF ASHWAGANDHA IN THE CURE OF COVID 19 PANDEMIC